Health care stocks started the week mixed amid a smattering of earnings, trial data and other news.AstraZeneca (AZN - Get Report) said Monday that its heart drug Brilinta worked better than Bristol-Myers Squibb's (BMY - Get Report) and Sanofi-Aventis' (SNY - Get Report) blockbuster blood-thinner Plavix in a study.
Health Winners and Losers: AstraZeneca
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.